| |
| |
|
| Insider
Information: |
Gold Mitchell |
| Relationship: |
Executive Chairman and... |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
457,263 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
457,263 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Dendreon Corp |
DNDN |
Director |
2013-01-03 |
457,263 |
2003-09-03 |
0 |
Premium* |
|
|
Alpine Immune Sciences Inc |
ALPN |
Executive Chairman and... |
2024-05-20 |
0 |
2024-05-18 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
140 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 5 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • • |
2021-02-02 |
4 |
AS |
$11.74 |
$117,381 |
D/D |
(10,000) |
290,039 |
0 |
% |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • • |
2021-02-01 |
4 |
AS |
$12.07 |
$128,665 |
D/D |
(10,000) |
300,039 |
0 |
% |
|
| DNDN |
Dendreon Corp |
President & CEO |
• – – |
2010-07-15 |
4 |
D |
$32.45 |
$129,346 |
D/D |
(3,986) |
220,373 |
0 |
- |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • • |
2021-03-05 |
4 |
AS |
$12.99 |
$129,875 |
D/D |
(10,000) |
270,039 |
0 |
% |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • • |
2021-03-04 |
4 |
AS |
$13.01 |
$130,108 |
D/D |
(10,000) |
280,039 |
0 |
% |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • – |
2023-12-08 |
4 |
AS |
$17.08 |
$137,784 |
D/D |
(8,067) |
101,320 |
0 |
% |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • • |
2020-12-31 |
4 |
D |
$12.60 |
$140,150 |
D/D |
(11,123) |
310,039 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & CEO |
• – – |
2010-10-15 |
4 |
D |
$37.83 |
$150,790 |
D/D |
(3,986) |
213,411 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & Chief Executive Of |
• – – |
2011-07-15 |
4 |
D |
$38.80 |
$154,657 |
D/D |
(3,986) |
248,188 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & CEO |
• – – |
2010-04-15 |
4 |
D |
$39.64 |
$158,005 |
D/D |
(3,986) |
511,998 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & Chief Executive Of |
• – – |
2011-04-15 |
4 |
D |
$42.40 |
$169,006 |
D/D |
(3,986) |
285,815 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & Chief Executive Of |
• – – |
2011-01-21 |
4 |
D |
$35.05 |
$179,631 |
D/D |
(5,125) |
289,801 |
0 |
- |
|
| DNDN |
Dendreon Corp |
CEO |
• • – |
2003-09-03 |
4 |
A |
$6.32 |
$221,200 |
D/D |
35,000 |
35,000 |
|
- |
|
| DNDN |
Dendreon Corp |
officerTitle |
• • – |
2006-01-19 |
4 |
A |
$5.50 |
$309,375 |
D/D |
56,250 |
107,183 |
|
- |
|
| DNDN |
Dendreon Corp |
President & Chief Executive Of |
• – – |
2010-01-15 |
4 |
D |
$29.05 |
$425,757 |
D/D |
(14,656) |
463,177 |
0 |
- |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • • |
2021-09-17 |
4 |
AS |
$10.01 |
$452,964 |
D/D |
(45,262) |
109,387 |
0 |
% |
|
| DNDN |
Dendreon Corp |
President & CEO |
• • – |
2007-04-02 |
4 |
OE |
$2.21 |
$491,806 |
D/D |
151,157 |
276,690 |
0 |
- |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • – |
2023-12-26 |
4 |
AS |
$20.22 |
$495,217 |
D/D |
(24,486) |
0 |
0 |
% |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • – |
2023-12-27 |
4 |
AS |
$20.04 |
$592,717 |
D/D |
(29,573) |
0 |
0 |
% |
|
| DNDN |
Dendreon Corp |
President & Chief Executive Of |
• – – |
2011-03-03 |
4 |
AS |
$33.03 |
$627,505 |
D/D |
(19,000) |
289,801 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & Chief Executive Of |
• – – |
2011-03-25 |
4 |
AS |
$33.21 |
$630,908 |
D/D |
(19,000) |
289,801 |
0 |
- |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • – |
2023-12-12 |
4 |
AS |
$17.32 |
$711,026 |
D/D |
(41,063) |
0 |
0 |
% |
|
| DNDN |
Dendreon Corp |
President & Chief Executive Of |
• – – |
2011-07-25 |
4 |
AS |
$38.37 |
$728,964 |
D/D |
(19,000) |
225,785 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & Chief Executive Of |
• – – |
2011-06-27 |
4 |
AS |
$38.69 |
$735,169 |
D/D |
(19,000) |
252,174 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & Chief Executive Of |
• – – |
2011-05-25 |
4 |
AS |
$40.00 |
$759,939 |
D/D |
(19,000) |
267,293 |
0 |
- |
|
140 Records found
|
|
Page 5 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
